|
|
|
The Great Cholesterol Con: The Truth About What Really Causes Heart Disease and How to Avoid It
|
(Buch) |
| Lieferstatus: |
 Auf Bestellung (Lieferzeit unbekannt) |
| Veröffentlichung: |
Juli 2008
|
| Genre: |
Ratgeber |
| ISBN: |
9781844546107 |
|
EAN-Code:
|
9781844546107 |
| Verlag: |
Kings Road Publishing |
| Einband: |
Kartoniert |
| Sprache: |
English
|
| Dimensionen: |
H 198 mm / B 129 mm / D 17 mm |
| Gewicht: |
187 gr |
| Seiten: |
288 |
| Bewertung: |
Titel bewerten / Meinung schreiben
|
| Inhalt: |
| Statins are the so-called wonder drugs widely prescribed to lower blood cholesterol levels and claim to offer unparalleled protection against heart disease. Believed to be completely safe and capable of preventing a whole series of other conditions, they are the most profitable drug in the history of medicine. In this groundbreaking book, GP Malcolm Kendrick exposes the truth behind the hype, revealing: high cholesterol levels don't cause heart disease; a high-fat diet - saturated or otherwise - does not affect blood cholesterol levels; and, the protection provided by statins is so small as to be not worth bothering about for most men and all women.Statins have many more side affects than has been admitted and their advocates should be treated with scepticism due to their links with the drugs' manufacturers.Kendrick lambastes a powerful pharmaceutical industry and unquestioning medical profession, who, he claims, perpetuate the madcap concepts of 'good' and 'bad' cholesterol and cholesterol levels to convince millions of people to spend billions of pounds on statins, thus creating an atmosphere of stress and anxiety - the real cause of fatal heart disease.With clarity and wit, "The Great Cholesterol Con" debunks our assumptions on what constitutes a healthy lifestyle and diet. It is the invaluable guide for anyone who thought there was a miracle cure for heart disease, an appeal to common sense and a controversial and fascinating breakthrough that will set dynamite under the whole area. |
|
Newsfeed | 
Facebook | 
Twitter
